NASDAQ · ANDE

Andersons Inc./The

$77.71 -$0.54 (-0.69%) 1D After hours
Session Pulse Overnight session 2 mentions today No new SEC filings since Mon close Full pulse →

Key Metrics

$2.66B
Market cap
20.72×
P/E · TTM
$10.98B
Revenue · TTM
$128.62M
Net income
EPS · TTM $3.75
Dividend yield 1.0%
Free cash flow −$104.94M
Beta · 1Y 0.06
EBITDA · TTM $305.24M
Gross margin 6.6%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    2 insider transaction filings hit the record.

    Form 4s are events, not verdicts — officers, directors, and 10% owners reporting their own trades. The forms post hours before the media writes them up.

    RECEIPT: SEC FORM 4 × 2, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 6
    The stock moved -13.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.66B
Enterprise value
Shares outstanding34.1M
52-wk range$31.84 – $82.11
Avg volume · 20D254.5K
Net cash
Book value / share$36.97
IndustryWholesale-Farm Product Raw Materials
ExchangeNASDAQ
About Andersons Inc./The
IPO dateFeb 20, 1996
Employees2137

Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E20.72
P/S0.24
P/FCF
EV/EBITDA
EV/Sales
Graham №$55.83

Profitability

Gross 6.6%
Operating 1.6%
Net 1.2%
FCF -1.0%
ROE / ROIC 9.8% · —

Financial Health

Current ratio1.37
Quick ratio0.62
Debt / equity0.47
Debt / EBITDA 1.94
Net cash
Working capital$686.48M

Cash Flow · TTM

Operating CF $133.34M
Capex −$238.29M
Free cash flow −$104.94M
Buybacks
Dividends paid $27.00M
Shareholder yield 1.0%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

4.1
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$55.83 vs $77.71
Trades 1.4× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings